激励步行改善慢性疾病指标:在中国东南地区的职业人口中进行了一项短期实地干预
Xiangju Hu1,2, Menglin Yu1, Zhifeng Lin1
1Fujian Provincial Key Laboratory of Environment Factors and Cancer, Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.
Frontiers in public health
|February 12, 2026
概括
一个为期100天的鼓励步行计划改善了职业队列中的慢性疾病指标. 更高的步行强度与更好的血压,体重和身体组成结果相关,支持工作场所的健康策略.
科学领域:
- 职业健康 职业健康 职业健康 职业健康
- 预防医学 预防医学
- 公共卫生 公共卫生
背景情况:
- 慢性疾病对公众健康构成重大挑战.
- 工作场所干预对于促进员工健康和福祉至关重要.
- 职业环境为实施有效的慢性疾病预防策略提供了机会.
研究的目的:
- 评估短期,激励步行干预对慢性疾病指标的影响.
- 在职业队列中探索预防和控制慢性疾病的有效策略.
- 评估步行强度与健康指标的改善之间的关系.
主要方法:
- 一个为期100天的监督步行干预,带有个人和团队激励.
- 使用统一的计步器监控步数.
- 在基线和终点收集人体测量 (身高,体重,腰/部周长,腰/部比,身体脂肪百分比) 的数据.
- 使用SPSS 26.0.0进行数据分析.
主要成果:
- 所有参与者都完成了干预,其中64.2%的人每天达到10,000步的目标.
- 在男性和女性的八个慢性疾病指标中观察到显著的改善.
- 静脉血压 (2.47 mmHg),静脉血压 (4.23 mmHg),体重 (1.60 kg),体重指数 (0.57 kg/m2),腰围 (1.33 cm),部周长 (0.86 cm),腰与部比率 (0.01) 和体脂百分比 (0.01%) 的降低.
- 显而易见的是,行走强度和健康指标的改善之间存在剂量依赖的关系.
结论:
- 短期步行干预显著改善了关键的身体指标,包括血压,BMI,腰围和身体脂肪百分比.
- 显著的BMI和腰围的减少突显了干预措施的有效性.
- 这些发现支持整合工作场所健康策略,以减轻非传染性疾病风险,等待进一步的受控研究.
相关概念视频
Indicators
61.1K
Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
61.1K
Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
Chronic Kidney Disease I: Introduction
766
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
766
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
Chronic Kidney Disease II: Clinical Manifestations
683
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
683


